Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome

J Schumann, EC Henrich, H Strobl… - Cochrane Database …, 2018 - cochranelibrary.com
Background Cardiogenic shock (CS) and low cardiac output syndrome (LCOS) as
complications of acute myocardial infarction (AMI), heart failure (HF) or cardiac surgery are …

The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials

A Belletti, ML Castro, S Silvetti, T Greco… - BJA: British Journal …, 2015 - academic.oup.com
Background Inotropes and vasopressors are frequently administered to critically ill patients
in order to improve haemodynamic function and restore adequate organ perfusion …

Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials

C Zhou, J Gong, D Chen, W Wang, M Liu… - American Journal of Kidney …, 2016 - Elsevier
Background Levosimendan has been shown to confer direct renoprotection in renal
endotoxemic and ischemia-reperfusion injury and could increase renal blood flow in …

Definitions of low cardiac output syndrome after cardiac surgery and their effect on the incidence of intraoperative LCOS: A literature review and cohort study

A Schoonen, WA van Klei, L van Wolfswinkel… - Frontiers in …, 2022 - frontiersin.org
Objectives Low cardiac output syndrome (LCOS) is a serious complication after cardiac
surgery. Despite scientific interest in LCOS, there is no uniform definition used in current …

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome

K Uhlig, L Efremov, J Tongers, S Frantz… - Cochrane Database …, 2020 - cochranelibrary.com
Background Cardiogenic shock (CS) and low cardiac output syndrome (LCOS) are
potentially life‐threatening complications of acute myocardial infarction (AMI), heart failure …

Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review …

F Sanfilippo, JB Knight, S Scolletta, C Santonocito… - Critical Care, 2017 - Springer
Background Previous studies have shown beneficial effects of levosimendan in high-risk
patients undergoing cardiac surgery. Two large randomized controlled trials (RCTs) …

A Bayesian network meta-analysis on the effect of inodilatory agents on mortality

T Greco, MG Calabrò, RD Covello… - British Journal of …, 2015 - academic.oup.com
Background Inodilators are commonly used in critically ill patients, but their effect on survival
has not been properly studied to date. The objective of this work was to conduct a network …

[HTML][HTML] Perioperative management of the patient at high-risk for cardiac surgery-associated acute kidney injury

B Milne, T Gilbey, G Kunst - Journal of Cardiothoracic and Vascular …, 2022 - Elsevier
Acute kidney injury is one of the most common major complications of cardiac surgery and it
is associated with increased morbidity and mortality. Cardiac surgery-associated acute …

Levosimendan reduces mortality and low cardiac output syndrome in cardiac surgery

C Weber, M Esser, K Eghbalzadeh… - The Thoracic and …, 2020 - thieme-connect.com
Background There has been conflicting evidence concerning the effect of levosimendan on
clinical outcomes in patients undergoing cardiac surgery. Therefore, we performed a …

Perioperative levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis

A Putzu, S Clivio, A Belletti, T Cassina - International journal of cardiology, 2018 - Elsevier
Background Several studies suggested beneficial effects of perioperative levosimendan on
postoperative outcome after cardiac surgery. However, three large randomized controlled …